PTC Therapeutics
PTCT
#3039
Rank
S$6.83 B
Marketcap
S$81.81
Share price
0.21%
Change (1 day)
-16.65%
Change (1 year)

EPS for PTC Therapeutics (PTCT)

EPS in 2026 (TTM): S-$1.67

According to PTC Therapeutics 's latest financial reports the company's current EPS (TTM) is S-$1.69. In 2025 the company made an earnings per share (EPS) of S$11.33 an increase over its 2024 EPS that were of S-$6.09.

EPS history for PTC Therapeutics from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S-$1.67-114.73%
2025S$11.33-285.84%
2024S-$6.09
2022S-$10.044.85%
2021S-$9.57
2019S-$5.7666.17%
2018S-$3.4729.33%
2017S-$2.68-50.12%
2016S-$5.37-17.59%
2015S-$6.5257.63%
2014S-$4.14

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
S$6.76-500.76%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vertex Pharmaceuticals
VRTX
S$20.19-1,296.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
S-$2.02 19.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
S-$3.39 100.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
S-$1.35-19.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
S-$5.39 219.08%๐Ÿ‡บ๐Ÿ‡ธ USA